These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 35067965)

  • 1. TAPPing into the potential of inducible tau/APP transgenic mice.
    Xu G; Ulm BS; Howard J; Fromholt SE; Lu Q; Lee BB; Walker A; Borchelt DR; Lewis J
    Neuropathol Appl Neurobiol; 2022 Apr; 48(3):e12791. PubMed ID: 35067965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the C57BL/6 strain background on tauopathy progression in the rTg4510 mouse model.
    Bailey RM; Howard J; Knight J; Sahara N; Dickson DW; Lewis J
    Mol Neurodegener; 2014 Jan; 9():8. PubMed ID: 24428919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tau reduction in the presence of amyloid-β prevents tau pathology and neuronal death in vivo.
    DeVos SL; Corjuc BT; Commins C; Dujardin S; Bannon RN; Corjuc D; Moore BD; Bennett RE; Jorfi M; Gonzales JA; Dooley PM; Roe AD; Pitstick R; Irimia D; Frosch MP; Carlson GA; Hyman BT
    Brain; 2018 Jul; 141(7):2194-2212. PubMed ID: 29733334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prominent tauopathy and intracellular β-amyloid accumulation triggered by genetic deletion of cathepsin D: implications for Alzheimer disease pathogenesis.
    Terron HM; Parikh SJ; Abdul-Hay SO; Sahara T; Kang D; Dickson DW; Saftig P; LaFerla FM; Lane S; Leissring MA
    Alzheimers Res Ther; 2024 Apr; 16(1):70. PubMed ID: 38575959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid β accelerates phosphorylation of tau and neurofibrillary tangle formation in an amyloid precursor protein and tau double-transgenic mouse model.
    Seino Y; Kawarabayashi T; Wakasaya Y; Watanabe M; Takamura A; Yamamoto-Watanabe Y; Kurata T; Abe K; Ikeda M; Westaway D; Murakami T; Hyslop PS; Matsubara E; Shoji M
    J Neurosci Res; 2010 Dec; 88(16):3547-54. PubMed ID: 20936700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo reactive astrocyte imaging using [
    Kong Y; Cao L; Wang J; Zhuang J; Xie F; Zuo C; Huang Q; Shi K; Rominger A; Li M; Wu P; Guan Y; Ni R
    J Neurol Sci; 2024 Jul; 462():123079. PubMed ID: 38878650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in Synaptic Dysfunction Between rTg4510 and APP/PS1 Mouse Models of Alzheimer's Disease.
    Gelman S; Palma J; Tombaugh G; Ghavami A
    J Alzheimers Dis; 2018; 61(1):195-208. PubMed ID: 29154272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early intervention of tau pathology prevents behavioral changes in the rTg4510 mouse model of tauopathy.
    Wang X; Smith K; Pearson M; Hughes A; Cosden ML; Marcus J; Hess JF; Savage MJ; Rosahl T; Smith SM; Schachter JB; Uslaner JM
    PLoS One; 2018; 13(4):e0195486. PubMed ID: 29624602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Home cage measures of Alzheimer's disease in the rTg4510 mouse model.
    Barabas AJ; Robbins LA; Gaskill BN
    Genes Brain Behav; 2022 Feb; 21(2):e12795. PubMed ID: 35044727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-related decline in white matter integrity in a mouse model of tauopathy: an in vivo diffusion tensor magnetic resonance imaging study.
    Sahara N; Perez PD; Lin WL; Dickson DW; Ren Y; Zeng H; Lewis J; Febo M
    Neurobiol Aging; 2014 Jun; 35(6):1364-74. PubMed ID: 24411290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of tau pathology in male rTg4510 mice fed with a curcumin derivative Shiga-Y5.
    Yanagisawa D; Hamezah HS; Durani LW; Taguchi H; Tooyama I
    PLoS One; 2018; 13(12):e0208440. PubMed ID: 30521594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tauopathy contributes to synaptic and cognitive deficits in a murine model for Alzheimer's disease.
    Stancu IC; Ris L; Vasconcelos B; Marinangeli C; Goeminne L; Laporte V; Haylani LE; Couturier J; Schakman O; Gailly P; Pierrot N; Kienlen-Campard P; Octave JN; Dewachter I
    FASEB J; 2014 Jun; 28(6):2620-31. PubMed ID: 24604080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation and oligomerization of α-synuclein associated with GSK-3β activation in the rTg4510 mouse model of tauopathy.
    Takaichi Y; Chambers JK; Inoue H; Ano Y; Takashima A; Nakayama H; Uchida K
    Acta Neuropathol Commun; 2020 Jun; 8(1):86. PubMed ID: 32560668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model.
    Helboe L; Egebjerg J; Barkholt P; Volbracht C
    Brain Res; 2017 Jun; 1665():22-35. PubMed ID: 28411086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased Cerebral Level of P2X7R in a Tauopathy Mouse Model by PET Using [
    Kong Y; Cao L; Wang J; Zhuang J; Liu Y; Bi L; Qiu Y; Hou Y; Huang Q; Xie F; Yang Y; Shi K; Rominger A; Guan Y; Jin H; Ni R
    ACS Chem Neurosci; 2024 Jun; 15(11):2112-2120. PubMed ID: 38776461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
    Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
    Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of tau post-translational modifications in rTg4510 mice, a model of tau pathology.
    Song L; Lu SX; Ouyang X; Melchor J; Lee J; Terracina G; Wang X; Hyde L; Hess JF; Parker EM; Zhang L
    Mol Neurodegener; 2015 Mar; 10():14. PubMed ID: 25881209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tracking progressive pathological and functional decline in the rTg4510 mouse model of tauopathy.
    Blackmore T; Meftah S; Murray TK; Craig PJ; Blockeel A; Phillips K; Eastwood B; O'Neill MJ; Marston H; Ahmed Z; Gilmour G; Gastambide F
    Alzheimers Res Ther; 2017 Sep; 9(1):77. PubMed ID: 28931441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-dependent impairment of memory and neurofibrillary tangle formation and clearance in a mouse model of tauopathy.
    Kubota T; Kirino Y
    Brain Res; 2021 Aug; 1765():147496. PubMed ID: 33894222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visual Evoked Potentials as an Early-Stage Biomarker in the rTg4510 Tauopathy Mouse Model.
    Parka A; Volbracht C; Hall B; Bastlund JF; Nedergaard M; Laursen B; Botta P; Sotty F
    J Alzheimers Dis; 2023; 93(1):247-262. PubMed ID: 37005884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.